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The rate of alcohol absorption is dependent on gastric emptying (GE). As the slowing of GE by fat is dependent on lipolysis, orlistat may increase
the rise in blood alcohol when alcohol is consumed with, or after, fat. The aim of the study was to evaluate the effects of orlistat on GE and blood
alcohol after an alcohol-containing drink following a fat ‘preload’, in healthy subjects. Ten healthy males consumed 120 ml cream with or without
120 mg orlistat, 30 min before an alcohol-containing drink labelled with 20 MBq [99 mTc]sulfur colloid on 2 d. GE, plasma alcohol and blood
glucose were measured. GE was slightly faster with orlistat (P,0·05) compared with control. Plasma alcohol at 15 min was slightly higher
with orlistat (0·034 (SEM 0·006) g/100 ml) v. control (0·029 (SEM 0·005) g/100 ml) (P,0·05), but there was no effect on the area under the
curve 0–240 min. The increase in blood glucose was greater with orlistat, for example, at 15 min (1·07 (SEM 0·2) mmol/l) v. control (0·75
(SEM 0·2) mmol/l) (P¼0·05). The rise in blood glucose and plasma alcohol were related (for example, at 15 min r 0·49; P¼0·03). In conclusion,
lipase inhibition accelerates GE of an alcohol-containing drink following a fat ‘preload’ with a minor increase in the initial rise in plasma alcohol.
Gastric emptying: Orlistat: Plasma alcohol: Blood glucose
The rate of gastric emptying is regulated primarily by feed-
back inhibition generated by the interaction of nutrients with
the small intestine (Hunt et al. 1985; Lin et al. 1989; Boro-
vicka et al. 2000; Rayner et al. 2001); the magnitude of this
feedback is dependent on the length of small intestine exposed
(Lin et al. 1989). Of the three macronutrients, fat is the most
potent in slowing gastric emptying, primarily because of its
higher energy density, and potentially also because its absorp-
tion rate is relatively slower (Lin et al. 1996). Accordingly,
consumption of fat before, or with, a meal slows gastric emp-
tying (Cunningham & Read, 1989; Stacher et al. 1990, 1991;
Davidson et al. 1999), and delays the absorption of orally
administered nutrients (Welch et al. 1987; Cunningham &
Read, 1989; Hebbard et al. 1995). For example, when lipid
is infused directly into the small intestine before the consump-
tion of, or incorporated into, a carbohydrate-containing
(potato) meal, the glycaemic response to that meal is substan-
tially less (Welch et al. 1987; Cunningham & Read, 1989). Fat
appears to be most potent in slowing gastric emptying when
given before, rather than with, a meal (Cunningham & Read,
1989). This is to be expected; it takes some time for small-
intestinal feedback mechanisms induced by fat to become
established (Feinle et al. 2003), and administration of fat
before a meal ensures that it would empty preferentially and
be partially digested in the small intestine before the meal is
consumed.
Like most drugs, alcohol is absorbed predominantly from
the small intestine; hence, pharmacological (Nimmo, 1976;
Johnson et al. 1991) or dietary (Horowitz et al. 1989; Hebbard
et al. 1995) factors that modify gastric emptying may affect
the rate of alcohol absorption (Holt, 1981). In particular, inter-
ventions that slow gastric emptying have the potential to mini-
mise the rise in blood alcohol concentrations, mainly by
decreasing the access of alcohol to the small-intestinal
mucosa and, possibly, by increasing ‘first-pass’ alcohol
metabolism by the liver and, possibly, the stomach (DiPadova
et al. 1987; Caballeria et al. 1989; Frezza et al. 1990). Anec-
dotal evidence that ingestion of fat (for example, olive oil)
before the consumption of alcohol may reduce inebriation is
consistent with this concept.
The lipase inhibitor, orlistat, is now used widely in the treat-
ment of obesity. As a result of inhibition of gastric and pan-
creatic lipase, orlistat, when given in a dose of 120 mg with
a meal, reduces dietary fat absorption by about 40 %
(Davidson et al. 1999). We have recently reported, in patients
with type 2 diabetes managed by diet, that acute adminis-
tration of orlistat potentiates the initial postprandial rise in
blood glucose after both an oil or aqueous drink containing
glucose (Pilichiewicz et al. 2003) and a high-fat, mashed
potato, meal (O’Donovan et al. 2004a). These observations
were not surprising, given that the slowing of gastric emptying
by fat is dependent on lipolysis (Carney et al. 1995;
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Schwizer et al. 1997; Borovicka et al. 2000), i.e. NEFA are
responsible for mediating small-intestinal feedback inhibition
(Feinle et al. 2003), and the rate of gastric emptying is a
major determinant of the glycaemic response to carbo-
hydrate-containing meals (Horowitz et al. 1993a; Jones et al.
1996; Rayner et al. 2001). Accordingly, we reasoned that orli-
stat has the potential to increase the magnitude of the rise in
blood alcohol when an alcohol-containing beverage is con-
sumed with fat, and that these effects were likely to be most
marked when fat was consumed before the alcohol. Perhaps
surprisingly, this concept has not been evaluated previously–
one study reported that orlistat had no effect on alcohol
absorption, but the drink contained carbohydrate only
(Melia et al. 1998).
We have now evaluated the effects of lipase inhibition on
gastric emptying and blood alcohol and glucose concentrations
after ingestion of an alcohol-containing drink consumed after
a fat ‘preload’, in healthy subjects.
Materials and methods
Subjects
Ten healthy adult males (age 29·5 (SE 3·7) years; BMI 23·1
(SE 0·8) kg/m2) were recruited by advertisement. No subject
had a history of gastrointestinal disease or surgery, significant
respiratory or cardiac disease, alcohol abuse, or epilepsy and
none smoked more than ten cigarettes per d, or was taking
medication known to affect gastrointestinal function. The
protocol was approved by the Research Ethics Committee of
the Royal Adelaide Hospital, and each subject gave written,
informed consent.
Protocol
Each subject was studied on two occasions, separated by an
interval of 4–7 d in randomised, single-blind order. Each
study commenced at 08.30 hours, following an overnight
fast (14 h for solids, 12 h for liquids), when an intravenous
cannula was inserted into an antecubital vein for blood
sampling. On both days, subjects consumed 120 ml full-fat
cream (Bulla Thick cream; Bulla Dairy Foods, Derrimut,
Victoria, Australia; carbohydrate 55·3 kJ (13·2 kcal), fat
1398 kJ (333·9 kcal), protein 44·4 kJ (10·6 kcal)) with or
without 120 mg orlistat (Xenicale; Roche Products Pty.,
Dee Why, NSW, Australia), which was mixed thoroughly
into the cream, 30 min before consuming a 230 ml drink
comprising 97 ml ‘Feel Good’ iced chocolate (Farmers
Union; National Foods Limited, Melbourne, Victoria,
Australia; carbohydrate 94·6 kJ (22·6 kcal), fat 19·3 kJ
(4·6 kcal), protein 82·9 kJ (19·8 kcal)), low-energy sweetener
(SPLENDAw; Johnson and Johnson Pacific, Broadway,
NSW, Australia; carbohydrate 77·9 kJ (18·6 kcal) and
66·5 ml vodka (Premium Vodka 2000 Millennium product;
Wyborowa SA Poznan, Poland; 20 g alcohol; 334·9 kJ
(80 kcal)) and 66·5 ml water labelled with 20 MBq
[99 mTc]sulfur colloid, while sitting in front of a g camera
(Collins et al. 1983; Horowitz et al. 1989; Johnson et al.
1991). Accordingly, the energy content of the cream
‘preload’ was 1497·6 kJ (357·7 kcal) and the drink contained
606·2 kJ (144·8 kcal), i.e. total energy 2103·9 kJ (502·5 kcal).
The drink was consumed over 5 min, and radioisotopic data
were acquired between 0 and 240 min (60 s frames for the
first 60 min, 3 min frames thereafter, with time 0 (t 0 min)
defined as the time of completion of the drink. Venous
blood samples (5–10 ml in volume) were collected at t
25, 15, 30, 45, 60, 75, 90, 105, 120, 150, 180, 210 and
240 min. Blood glucose was measured on all of the samples;
plasma alcohol was measured on the samples obtained at t
25, 15, 30, 60, 90, 120, 150 and 240 min. Subjects were
allowed to leave the laboratory after 5 h and were asked
to record any gastrointestinal symptoms and their bowel
habit over the following 48 h.
Measurements
Gastric emptying. Data were corrected for subject move-
ment, radionuclide decay and g-ray attenuation (Collins et al.
1983; Pilichiewicz et al. 2003). Gastric emptying curves were
derived by drawing a region-of-interest around the total
stomach, from which the intragastric content at t 0, 15, 30,
45, 60, 75, 90, 120, 150, 180 and 240 min and the 50 % gastric
emptying time were calculated (Collins et al. 1983).
Blood glucose and plasma alcohol concentrations. Blood
glucose concentrations were determined immediately using a
portable glucose meter (Medisense Precision QID; Abbott Lab-
oratories, Bedford, MA, USA). The accuracy of this method has
been confirmed in our laboratory using the hexokinase technique
(Horowitz et al. 1996). The maximum increase in blood glucose
from baseline (i.e. t 25 min), and the areas under the curve
(AUC) for the change in blood glucose between 25 to 30 min,
25 to 60 min and 25 to 240 min, were calculated. Blood
samples for determination of plasma alcohol were collected in
ice-chilled tubes. Plasma was separated by centrifugation and
stored at 2708C for subsequent analysis by chromatography
(Cooper, 1971). The maximum increase in blood alcohol from
baseline, and the AUC between 25 to 30 min, 25 to 60 min
and 25 to 240 min, were calculated.
Statistical analysis
Data were evaluated using repeated-measures ANOVA and
are presented as means with their standard errors. Mean con-
trasts were used to analyse individual point-by-point compari-
sons. AUC for blood glucose and plasma alcohol were
calculated using the trapezoidal rule and compared using
Student’s paired t test. Relationships between gastric emptying
and the early rise in blood glucose and plasma alcohol concen-
trations were assessed using linear regression analysis.
P,0·05 was considered significant in all analyses.
Results
All subjects tolerated the study well; two subjects reported
loose bowel actions after orlistat – in both cases the symptoms
were mild and resolved within 48 h. All subjects experienced
no gastrointestinal symptoms.
Gastric emptying
Gastric emptying was faster with orlistat (P,0·05) when
compared with the drink without orlistat (Fig. 1(a)), although
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there was no significant difference in the 50 % gastric
emptying time (orlistat 102·8 (SEM 8·3) min v. control
116·0 (SEM 10·9) min).
Plasma alcohol and blood glucose concentrations
Plasma alcohol concentrations increased after the drinks on
both study days (P,0·05). The plasma alcohol concentration
at t 15 min was slightly higher with orlistat (orlistat 0·034
(SEM 0·006) g/100 ml v. control 0·029 (SEM 0·005) g/100 ml;
P,0·05). There was no overall difference in plasma alcohol
concentrations (P¼0·65), or peak blood alcohol (orlistat
0·045 (SEM 0·003) g/100 ml v. control 0·044 (SEM 0·004)
g/100 ml) between the two study days (Fig. 1(b)). There was
no significant difference between orlistat and control in the
AUC between 25 to 30 min (orlistat 0·82 (SEM 0·11)
g/100 ml £ min v. control 0·74 (SEM 0·10) g/100 ml £ min,
25 to 60 min (orlistat 1·94 (SEM 0·15) g/100 ml £ min v. con-
trol 1·86 (SEM 0·19) g/100 ml £ min and 25 to 240 min (orli-
stat 4·30 (SEM 0·32) g/100 ml £ min v. control 4·22 (SEM 0·40)
g/100 ml £ min).
There was no significant difference in the baseline (i.e.
t 25 min) blood glucose concentration between the two study
days. Blood glucose increased (P,0·05) after the drink on
both days (Fig. 1(c)). The magnitude of the rise from baseline
was greater at both 15 min (orlistat 1·07 (SEM 0·2) mmol/l v. con-
trol 0·75 (SEM 0·2) mmol/l; P¼0·05) and at 30 min (orlistat 1·06
(SEM 0·1) mmol/l v. control 0·51 (SEM 0·3) mmol/l; P¼0·001)
after orlistat. There was no overall difference in the rise from
baseline (P¼0·31) or peak blood glucose (orlistat 6·87 (SEM
0·17) mmol/l v. control 6·97 (SEM 0·28) mmol/l) between the
2 d (Fig. 1(c)). There was also no significant difference between
orlistat and control in the AUC between 25 to 30 min (orlistat
22·83 (SEM 3·87) mmol/l £ min v. control 12·90 (SEM 4·56)
mmol/l £ min), 25 to 60 min (orlistat 37·90 (SEM 3·39) mmol/
l £ min v. control 17·85 (SEM 11·70) mmol/l £ min) and 25 to
240 min (orlistat 31·83 (SEM 13·04) mmol/l £ min v. control
218·53 (SEM 39·70) mmol/l £ min).
Relationships between plasma alcohol and blood glucose
concentrations and gastric emptying
There was a significant inverse relationship between plasma
alcohol concentrations and the 50 % gastric emptying time
in the total group; for example, at t 30 min (r 2 0·65;
P¼0·002), which was not significant in the orlistat
(r 2 0·57; P¼0·08), but significant in the control (r 2 0·65;
P¼0·02), group (Fig. 2(a)). There was a significant inverse
relationship between the blood glucose concentration and gas-
tric emptying in the total group; for example, at t 15 min
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Fig. 2. Relationships between (a) plasma alcohol concentrations at 30 min and the 50 % emptying time (T50) for gastric emptying (r 20·65; P¼0·002), (b) the rise
in blood glucose from baseline and the intragastric retention at 15 min (r 20·46; P¼0·04) and (c) the plasma alcohol concentration at 15 min and the rise in blood
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Fig. 1. (a) Gastric emptying, (b) plasma alcohol and (c) blood glucose concentrations in response to a drink containing 20 g alcohol, consumed 30 min after inges-
tion of 120 ml cream with (–†–) or without (–W–; control) orlistat. Data are means, with their standard errors represented by vertical bars. Mean value was sig-
nificantly different from that of control: * P,0·05, * *P¼0·001. The presence of orlistat had a significant effect on gastric emptying (ANOVA); P,0·05. For details
of subjects and procedures, see p. 884
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(r 2 0·46; P¼0·04), which was significant in the orlistat
(r 2 0·66; P¼0·03), but not the control (r 2 0·24; P¼0·3)
group (Fig. 2(b)). There was a direct relationship between
blood glucose and plasma alcohol concentrations in the total
group; for example, at t 15 min (r 0·49; P¼0·03), which was
not significant in the orlistat (r 0·61; P¼0·06) or control
(r 0·34; P¼0·34), groups (Fig. 2(c)).
Discussion
Orlistat is a potent inhibitor of lipase in the gastrointestinal
tract (Borgstrom, 1988; Drent & van der Veen, 1993;
O’Donovan et al. 2004a) and is used widely in the manage-
ment of obesity. The present study demonstrates that in
healthy male subjects the incorporation of orlistat into a
cream ‘preload’ accelerates gastric emptying of an alcohol-
containing drink consumed 30 min later, and this is associated
with an initially greater blood alcohol and glycaemic response,
although these effects were all relatively modest and unlikely
to be of clinical significance. Both alcohol absorption and
postprandial glucose concentrations were shown to be depen-
dent on the rate of gastric emptying, as has been noted pre-
viously (Horowitz et al. 1989; Rayner et al. 2001).
Moreover, the magnitude of the elevation in blood alcohol
and glucose were shown to be related, which, while not unex-
pected, has not to our knowledge been demonstrated
previously.
Melia et al. (1998) reported that short-term treatment with
orlistat had no effect on alcohol absorption after a drink con-
taining 13·9 g carbohydrate and 41·7 g alcohol, which is not
surprising, given the absence of fat (Melia et al. 1998). It
has been well established that gastric emptying of carbo-
hydrate has a major influence on postprandial glycaemia
accounting for about 35 % of the variance in the initial
blood glucose response to 75 g oral glucose loads in cross-sec-
tional studies of healthy subjects (Horowitz et al. 1993a) and
patients with type 2 diabetes (Jones et al. 1996). In our present
study, subjects consumed a high-fat ‘preload’ before a drink
that predominantly comprised carbohydrate, since the effects
of fat to slow gastric emptying were likely to be more
marked than if the fat was included in the drink (Welch
et al. 1987; Cunningham & Read, 1989). If it is assumed
that the cream emptied from the stomach at a rate of about
12·6 kJ/min (3 kcal/min) (Edelbroek et al. 1993), some 25 %
should have entered the small intestine at the time of ingestion
of the drink. The presence of digested and digestible fat in the
small intestine would be expected to slow gastric emptying of
the drink (Stacher et al. 1991). The observed relationships
between both plasma alcohol and blood glucose responses
with gastric emptying are consistent with previous reports
(Nimmo, 1976; Holt, 1981; Horowitz et al. 1993a; Jones
et al. 1996), which have established that the latter is evident
even after low carbohydrate loads (O’Donovan et al. 2004b;
Chaikomin et al. 2005). It should be acknowledged that the
present study was not specifically designed to evaluate
relationships. It is therefore not surprising that correlations
were more evident in the total group (n 20) rather than in
the individual groups (n 10).
The magnitude of the acceleration of gastric emptying by
orlistat was small, as reflected in the blood alcohol and glu-
cose responses. There are a number of possible explanations
for this. The acceleration of gastric emptying by orlistat may
potentially have been more marked if the fat were consumed
as a liquid emulsion (Schwizer et al. 1997) and if the fat con-
tent of the alcohol-containing drink had been higher, given
that the effects of lipase inhibition on gastric emptying are
dependent on the fat load (Schwizer et al. 1997; Borovicka
et al. 2000). As our subjects were studied in the sitting pos-
ition it is possible that, because of its lower density, ingestion
of the drink would result in ‘layering’ of some, or all, of the
remaining intragastric fat (Horowitz et al. 1993b); if so, the
carbohydrate would empty preferentially and, thereby, regu-
late gastric emptying. While the orlistat was mixed thoroughly
into the cream, the latter is a stabilised droplet emulsion of fat
in which protein encases the fat droplets, and may have lim-
ited access of orlistat to the fat surface.
Had the differences in gastric emptying been more pro-
nounced we would have expected higher initial postprandial
rises in both plasma alcohol and blood glucose concentrations
(as we have shown previously in patients with type 2 diabetes
(Pilichiewicz et al. 2003; O’Donovan et al. 2004a)), which
may have significant implications for driving a motor vehicle
or operating machinery, and for glycaemic control in patients
with diabetes. This is of major relevance to patients with dia-
betes given that postprandial glycaemia affects glycated Hb
(Bastyr et al. 2000) and may also be an independent risk factor
for macrovascular disease (Saydah et al. 2001; Del Prato, 2002).
It could be expected that in patients with delayed gastric
emptying, the potential effects of orlistat on gastric emptying,
blood alcohol and postprandial glycaemia may be reduced;
however, this has not been previously studied.
Because of the potential limitations to the present study the
provisional conclusion that orlistat does not have any mean-
ingful effect on alcohol absorption in healthy subjects
should be treated circumspectly.
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